Aurora Cannabis Inc. has signed an agreement to buy Anandia Laboratories Inc. in an all-stock deal valued at $115-million.
Anandia provides research and development services as well as analytical testing for clients licensed under Canada’s medical cannabis rules.
Aurora CEO Terry Booth says the deal expands his company’s capabilities and will help accelerate product development.
Top Image: © Miravision | Adobe Stock